283 related articles for article (PubMed ID: 158033)
1. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.
Panasci LC; Green D; Schein PS
J Clin Invest; 1979 Oct; 64(4):1103-11. PubMed ID: 158033
[TBL] [Abstract][Full Text] [Related]
2. Biological and biochemical properties of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea (NSC D 254157), a nitrosourea with reduced bone marrow toxicity.
Fox PA; Panasci LC; Schein PS
Cancer Res; 1977 Mar; 37(3):783-7. PubMed ID: 138478
[TBL] [Abstract][Full Text] [Related]
3. Repair of DNA alkylation induced in L1210 leukemia and murine bone marrow by three chloroethylnitrosoureas.
Ahlgren JD; Green DC; Tew KD; Schein PS
Cancer Res; 1982 Jul; 42(7):2605-8. PubMed ID: 6211225
[TBL] [Abstract][Full Text] [Related]
4. Biological and biochemical properties of the 2-hydroxyl metabolites of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
Heal JM; Fox PA; Doukas D; Schein PS
Cancer Res; 1978 Apr; 38(4):1070-4. PubMed ID: 147730
[TBL] [Abstract][Full Text] [Related]
5. Correlation of nitrosourea murine bone marrow toxicity with deoxyribonucleic acid alkylation and chromatin binding sites.
Green D; Tew KD; Hisamatsu T; Schein PS
Biochem Pharmacol; 1982 May; 31(9):1671-9. PubMed ID: 7104031
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
Cantrell JE; Green D; Schein PS
Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728
[TBL] [Abstract][Full Text] [Related]
7. Chlorozotocin, 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose, an antitumor agent with modified bone marrow toxicity.
Anderson T; McMenamin MG; Schein PS
Cancer Res; 1975 Mar; 35(3):761-5. PubMed ID: 123170
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the biological and biochemical properties of 1-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose.
Nagourney RA; Fox P; Schein PS
Cancer Res; 1978 Jan; 38(1):65-8. PubMed ID: 145314
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of chlorozotocin Nsc-178248), a new nitrosourea antitumor agent.
Schein PS; Panasci L; Woolley PV; Anderson T
Cancer Treat Rep; 1976 Jun; 60(6):801-5. PubMed ID: 133756
[TBL] [Abstract][Full Text] [Related]
10. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity studies of methylnitrosourea antitumor agents with reduced murine bone marrow toxicity.
Panasci LC; Fox PA; Schein PS
Cancer Res; 1977 Sep; 37(9):3321-8. PubMed ID: 141978
[No Abstract] [Full Text] [Related]
12. Comparison of the transport of chlorozotocin and CCNU in L1210 leukemia and murine bone marrow cells in vitro.
Lazarus P; Germina JS; Dufour M; Palmer G; Wallace D; Panasci LC
Cancer Chemother Pharmacol; 1983; 11(3):159-61. PubMed ID: 6227421
[TBL] [Abstract][Full Text] [Related]
13. Cellular and molecular mechanisms of the bone marrow sparing effects of the glucose chloroethylnitrosourea chlorozotocin.
Byrne P; Tew K; Jemionek J; MacVittie T; Erickson L; Schein P
Blood; 1984 Apr; 63(4):759-67. PubMed ID: 6322885
[TBL] [Abstract][Full Text] [Related]
14. 6-[Bis(2-chloroethyl)amino]-6-deoxygalactopyranose hydrochloride (C6-galactose mustard), a new alkylating agent with reduced bone marrow toxicity.
Schein PS; Green D; Dean SW; McPherson E
Cancer Res; 1987 Feb; 47(3):696-9. PubMed ID: 3802075
[TBL] [Abstract][Full Text] [Related]
15. Preclinical and clinical studies on chlorozotocin, a new nitrosourea with decreased bone marrow toxicity.
Macdonald JS; Hoth D; Schein PS
Recent Results Cancer Res; 1980; 70():83-9. PubMed ID: 6444466
[TBL] [Abstract][Full Text] [Related]
16. Biologic activity of MCNU: a new antitumor agent.
Sekido S; Ninomiya K; Iwasaki M
Cancer Treat Rep; 1979 Jun; 63(6):961-70. PubMed ID: 466655
[TBL] [Abstract][Full Text] [Related]
17. Effect of thymidine on uptake, DNA alkylation, and DNA repair in L1210 cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea or 3'-[3-(2-chloroethyl)-3-nitrosoureido]-3'-deoxythymidine.
August EM; Prusoff WH
Cancer Res; 1988 Aug; 48(15):4272-5. PubMed ID: 3390823
[TBL] [Abstract][Full Text] [Related]
18. DNA repeat length in chromatin from murine bone marrow and L1210 leukaemia cells.
Dean SW; Tew KD; Clark AE; Schein PS
Br J Cancer; 1985 Sep; 52(3):377-82. PubMed ID: 2931097
[TBL] [Abstract][Full Text] [Related]
19. Comparative studies on the antitumor activity and the bone marrow toxicity of 1-(beta-D-glucopyranosyl)-3-(2-chloroethyl)-3-nitrosourea and 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose.
Aoshima M; Sakurai Y
Gan; 1977 Apr; 68(2):247-50. PubMed ID: 892299
[TBL] [Abstract][Full Text] [Related]
20. 3-(Tetraacetyl glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea, an antitumor agent with modified bone marrow toxicity.
Schein PS; McMenamin MG; Anderson T
Cancer Res; 1973 Sep; 33(9):2005-9. PubMed ID: 4353476
[No Abstract] [Full Text] [Related]
[Next] [New Search]
